Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology Learning Network
The prevalence of HRR deficiencies has been found to be as high as 20% to 30% in patients with mCRPC, a significantly higher rate than that in patients with localized disease.
Oncology, Medical March 31st 2025
Cancer Therapy Advisor
Comprehensive genetic profiling now plays a central role in ovarian cancer management, with mandatory offering of both germline and somatic testing for all patients at diagnosis.
Oncology, Medical February 20th 2025
Cleveland Clinic Journal of Medicine (CCJM)
One in eight women will develop breast cancer in her lifetime, with risk-reducing medications showing up to 65% reduction in annual incidence, yet these interventions remain vastly underutilized in clinical practice.
Oncology, Medical January 7th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS